Lotrimin AF
Executive Summary
Schering's OTC antifungal product will be available beginning in July. The 1% clotrimazole topical-liquid and cream formulations are indicated for the self-treatment of athlete's foot, jock itch and ringworm. Lotrimin AF, which will be positioned as a professional product vis a vis the consumer orientation for Tinactin, was approved Oct. 27 ("The Pink Sheet" Oct. Oct. 30, T&G-1).